unisol 05 oral solution for piglets - Resultados da pesquisa

Índia - inglês - Central Drugs Standard Control Organization

qunisol 5 ml dps

ochoa - ciprofloxacin,hydroxy propyl methylcellulose,benzalkonium chl. - dps - 0.3,0.25,0.02;% all w/v - 5 ml

Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

unisol 100 mg/ml sol. for drinking water

vetpharma animal health s.l. - enrofloxacin 100 mg/ml - solution for use in drinking water - 100 mg/ml - enrofloxacin 100 mg/ml - enrofloxacin - poultry

Filipinas - inglês - FDA (Food And Drug Administration)

unisolve formulation: each ml contains: sucrose .......... 20 mg sodium chloride...............5.69 mg disodium phosphate dehydr

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - sterile phosphate buffered saline (vet.) - solution for freeze dried vaccine (im/sc) - formulation: each ml contains: sucrose .......... 20 mg sodium chloride...............5.69 mg disodium phosphate dehydrate .....

Filipinas - inglês - FDA (Food And Drug Administration)

unisolve formulation: each ml contains: sucrose..................................20 mg sodium chloride.........................5.69 mg disodium phosphate dehydrate......1.28 mg potassium dihydrogen phosphate....520 mcg sterile water. .......... 1 ml solution for freeze-dried vaccine (im/sc)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - sterile phosphate buffered saline (vet.) - solution for freeze-dried vaccine (im/sc) - formulation: each ml contains: sucrose..................................20 mg sodium chloride.........................5.69 mg disodium phosphate dehydrate......1.28 mg potassium dihydrogen phosphate....520 mcg sterile water. .......... 1 ml

Estados Unidos - inglês - NLM (National Library of Medicine)

montelukast sodium- montelukast sodium tablet, coated

remedyrepack inc. - montelukast sodium (unii: u1o3j18sfl) (montelukast - unii:mhm278sd3e) - montelukast 10 mg - montelukast sodium tablets, chewable tablets and oral granules are indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. montelukast sodium tablets and chewable tablets are indicated for prevention of exercise-induced bronchoconstriction (eib) in patients 6 years of age and older. montelukast sodium tablets, chewable tablets and oral granules are indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older. - hypersensitivity to any component of this product. risk summary available data from published prospective and retrospective cohort studies over decades with montelukast use in pregnant women have not established a drug-associated risk of major birth defects [see data] . in animal reproduction studies, no adverse developmental effects were observed with oral administration of montelukast to pregnant rats and rabbits during org